The Native Antigen Company expands its range of Omicron antigens to include BA.5 variant

Scientist researcher chemist doctor working with transparent glassware mixing liquid solution during microbiology experiment in hospital laboratory. Medical equipment on table. Medicine concept

The Native Antigen Company (part of LGC Clinical Diagnostics), one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, today announced the commercial launch of its latest SARS-CoV-2 antigens for the newly designated Omicron BA.5 variant.

MGI Partners with Imperial College London to Establish Overseas Customer Experience Center in the UK

Previous article

Today’s top deals feature the Breville Smart Oven Air Fryer, Acer Predator Helios 300 gaming laptop, and more

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News